Frazier Life Sciences Management, L.P.: MAZE THERAPEUTICS INC (MAZE): Quarterly 13F Position History
As of Q2 2026, Frazier Life Sciences Management, L.P. reported 5,032,915 shares of MAZE THERAPEUTICS INC (MAZE), worth $150.2M and representing 3.3% of its 13F equity book. Quarter-over-quarter share count change: + 465,641 (+10.2%) . The position first appeared in Q1 2025 and has been disclosed across 6 13F-HR filings in Pactolio's tracked window.
- 5,032,915Shares Held (Latest Filing)
- $150.2MReported Market Value (Latest Filing)
- 3.3%Portfolio Weight (% of 13F Equity Book)
- +465,641Quarter-over-Quarter Share Change
- +$13.8MQuarter-over-Quarter Value Change
- 5,032,915Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 6 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,032,915 | +465,641 | +10.2% | $150.2M | 3.3% | $29.8 |
| Q1 2026 | 4,567,274 | 0 | – | $136.3M | 3.5% | $29.9 |
| Q4 2025 | 4,567,274 | 0 | – | $189.2M | 5.1% | $41.4 |
| Q3 2025 | 4,567,274 | 1 | -0.0% | $118.4M | 3.5% | $25.9 |
| Q2 2025 | 4,567,275 | +438,274 | +10.6% | $56.0M | 2.2% | $12.3 |
| Q1 2025 | 4,129,001 | – | – | $45.5M | 2.1% | $11.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Frazier Life Sciences Management, L.P. first disclose a MAZE position in 13F-HR filings?
Frazier Life Sciences Management, L.P. first reported MAZE THERAPEUTICS INC (MAZE) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 6 reported quarters within Pactolio's tracked window.
What was Frazier Life Sciences Management, L.P.'s most recent quarter-over-quarter share-count change in MAZE?
Between Q1 2026 and Q2 2026, Frazier Life Sciences Management, L.P. added 465,641 shares of MAZE (+10.2%), bringing the total reported position to 5,032,915 shares at a market value of $150.2M.
Does the implied price-per-share represent Frazier Life Sciences Management, L.P.'s cost basis in MAZE?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.